This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-KLK3 monoclonal antibody, clone 6B7 [FITC]
catalog :
DCABH-6578
quantity :
50 μg
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
6B7
reactivity :
human
application :
western blot, ELISA
product information
Cat :
DCABH-6578
Product Name :
Anti-KLK3 monoclonal antibody, clone 6B7 [FITC]
Brand :
Creative Diagnostics
Abbr :
Anti-KLK3 MAb, FITC-Conjugated
Host animal :
Mouse
Clone :
6B7
Official Symbol :
KLK3
Clonality :
Monoclonal
Application :
WB, ELISA, sELISA
Target :
KLK3
Species Reactivity :
Human
Conjugate :
FITC
Antibody Type :
Primary Antibodies
Immunogen :
Full length protein (Human PSA antigen purified from semenal plasma).
Alternative Names :
KLK3; kallikrein-related peptidase 3; APS, kallikrein 3, (prostate specific antigen); prostate-specific antigen; PSA; seminin; P-30 antigen; kallikrein-3; semenogelase; gamma-seminoprotein; prostate specific antigen; APS; hK3; KLK2A1;
UniProt ID :
P07288
Antibody Isotype :
IgG2a
Size :
50 μg
Storage :
Store at +4°C.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments